EDGAR CASTILLO-ARMAS: Open Payments
NPI 1851492847 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,908 in 87 payments from 13 companies in 2025. Trend: 2023 $2,892 · 2024 $3,329 · 2025 $2,908
Food & beverage: $2,708Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $781 |
| Vanda Pharmaceuticals Inc. | 8 | $344 |
| Axsome Therapeutics, Inc. | 8 | $318 |
| Alkermes, Inc. | 10 | $281 |
| E.R. Squibb & Sons, L.L.C. | 9 | $264 |
| Otsuka America Pharmaceutical, Inc. | 12 | $245 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Lundbeck LLC | 7 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Janssen Pharmaceuticals, Inc | 5 | $72 |
Products named: CAPLYTA, FANAPT, Auvelity, REXULTI, SPRAVATO, COBENFY, ARISTADA, INGREZZA.
Industry payments across CA — which companies pay providers there.
